Deleterious Variants of FIG4, a Phosphoinositide Phosphatase, in Patients with ALS

American Journal of Human Genetics

Volumn 84, Issue 1, 2009, Pages 85-88

  Chow, Clement Y ^a   Landers, John E ^b,c   Bergren, Sarah K ^a   Sapp, Peter C ^b,c,e   Grant, Adrienne E ^a   Jones, Julie M ^a   Everett, Lesley ^a   Lenk, Guy M ^a   McKenna Yasek, Diane M ^b,c   Weisman, Lois S ^d   Figlewicz, Denise ^a   Brown, Robert H ^b,c   Meisler, Miriam H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOSINE; GUANINE; POLYPHOSPHOINOSITIDE; THYMINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHROMOSOME 6Q; CONTROLLED STUDY; DISEASE DURATION; DNA DETERMINATION; DOMINANT INHERITANCE; FAMILY HISTORY; FEMALE; GENE DELETION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEREDITARY MOTOR SENSORY NEUROPATHY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIMARY LATERAL SCLEROSIS; PRIORITY JOURNAL; RECESSIVE INHERITANCE; RISK FACTOR; SEQUENCE ANALYSIS; SEX RATIO;

ADULT; AGED; AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; FLAVOPROTEINS; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOTOR NEURON DISEASE; MUTATION;

EID: 58049192812     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2008.12.010     Document Type: Article

References (20)

1. Volpicelli-Daley L., and De Camilli P. Phosphoinositides' link to neurodegeneration. Nat. Med. 13 (2007) 784-786
2. Rutherford A.C., Traer C., Wassmer T., Pattni K., Bujny M.V., Carlton J.G., Stenmark H., and Cullen P.J. The mammalian phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) regulates endosome-to-TGN retrograde transport. J. Cell Sci. 119 (2006) 3944-3957
3. Zhang Y., Zolov S.N., Chow C.Y., Slutsky S.G., Richardson S.C., Piper R.C., Yang B., Nau J.J., Westrick R.J., Morrison S.J., et al. Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. Proc. Natl. Acad. Sci. USA 104 (2007) 17518-17523
4. Chow C.Y., Zhang Y., Dowling J.J., Jin N., Adamska M., Shiga K., Szigeti K., Shy M.E., Li J., Zhang X., et al. Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 448 (2007) 68-72
5. Zhang X., Chow C.Y., Sahenk Z., Shy M.E., Meisler M.H., and Li J. Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. Brain 131 (2008) 1990-2001
6. Pasinelli P., and Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7 (2006) 710-723
7. Schymick J.C., Talbot K., and Traynor B.J. Genetics of sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 16 (2007) R233-R242
8. Escayg A., MacDonald B.T., Meisler M.H., Baulac S., Huberfeld G., An-Gourfinkel I., Brice A., LeGuern E., Moulard B., Chaigne D., et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat. Genet. 24 (2000) 343-345
9. Rainier S., Sher C., Reish O., Thomas D., and Fink J.K. De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy. Arch. Neurol. 63 (2006) 445-447
10. Duex J.E., Tang F., and Weisman L.S. The Vac14p-Fig4p complex acts independently of Vac7p and couples PI3,5P2 synthesis and turnover. J. Cell Biol. 172 (2006) 693-704
11. Hughes W.E., Cooke F.T., and Parker P.J. Sac phosphatase domain proteins. Biochem. J. 350 (2000) 337-352
12. Vorechovsky I. Aberrant 3′ splices sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res. 34 (2006) 4630-4641
13. Buratti E., Chivers M., Královicová J., Romano M., Baralle M., Krainer A.R., and Vorechovsky I. Aberrant 5′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res. 35 (2007) 4250-4263
14. 2 levels in yeast and mouse. EMBO J. (2008) Published online November 27, 2008
15. Bolino A., Muglia M., Conforti F.L., LeGuern E., Salih M.A., Georgiou D.M., Christodoulou K., Hausmanowa-Petrusewicz I., Mandich P., Schenone A., et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 25 (2000) 17-19
16. Senderek J., Bergmann C., Weber S., Ketelsen U.P., Schorle H., Rudnik-Schöneborn S., Büttner R., Buchheim E., and Zerres K. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum. Mol. Genet. 12 (2003) 349-356
17. Stendel C., Roos A., Deconinck T., Pereira J., Castagner F., Niemann A., Kirschner J., Korinthenberg R., Ketelsen U.P., Battaloglu E., et al. Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, frabin/FGD4. Am. J. Hum. Genet. 81 (2007) 158-164
18. Delague V., Jacquier A., Hamadouche T., Poitelon Y., Baudot C., Boccaccio I., Chouery E., Chaouch M., Kassouri N., Jabbour R., et al. Mutations in FGD4 encoding the Rho GDP/GTP exchange factor FRABIN cause autosomal recessive Charcot-Marie-Tooth type 4H. Am. J. Hum. Genet. 81 (2007) 1-16
19. Hanein S., Martin E., Boukhris A., Byrne P., Goizet C., Hamri A., Benomar A., Lossos A., Denora P., Fernandez J., et al. Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. Am. J. Hum. Genet. 82 (2008) 992-1002
20. Valdmanis P.N., and Rouleau G.A. Genetics of familial amyotrophic lateral sclerosis. Neurology 70 (2008) 144-152